HF
VTYX

HRT Financial’s Ventyx Biosciences VTYX Stock Holding History

HRT Financial’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-91,434
Closed -$195K – 3756
2025
Q2 		$195K Buy
+91,434
New +$148K ﹤0.01% 2085
2023
Q3 		– Sell
-22,397
Closed -$734K – 3173
2023
Q2 		$734K Buy
+22,397
New +$772K 0.01% 1138
2022
Q1 		– Sell
-33,963
Closed -$674K – 3949
2021
Q4 		$674K Buy
+33,963
New +$644K ﹤0.01% 1531

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's VTYX Position: Q3 2025 in Review

HRT Financial sold out of Ventyx Biosciences (VTYX) in Q3 2025, closing a stake of 91,434 shares — an estimated $195K sold.

HRT Financial first reported a position in VTYX in Q4 2021 and held it in 3 quarters. The position peaked at $734K in Q2 2023. 110 funds tracked by Wall St. Rank hold VTYX as of Q3 2025.

  • HRT Financial reported no remaining Ventyx Biosciences position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 91,434 Ventyx Biosciences shares in Q3 2025, an estimated $195K.
  • HRT Financial first reported a position in Ventyx Biosciences in Q4 2021 and held it in 3 quarters.
  • HRT Financial's Ventyx Biosciences position peaked at $734K in Q2 2023.
  • 110 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.